Xycrobe signs research deal with Johnson & Johnson Consumer
Xycrobe Therapeutics has entered into a research agreement with Johnson & Johnson Consumer.
The collaboration, facilitated by Johnson & Johnson Innovation, is focused on further understanding applications of Xycrobe's platform technology developed for the treatment of inflammatory skin diseases.
Click on this link for more information.
